DocMorris AG (OTCMKTS:ZRSEF – Get Free Report) was the target of a significant drop in short interest during the month of June. As of June 15th, there was short interest totaling 156,154 shares, a drop of 45.9% from the May 31st total of 288,775 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is currently ∞ days.
DocMorris Stock Performance
OTCMKTS:ZRSEF opened at $7.45 on Thursday. DocMorris has a 12 month low of $7.45 and a 12 month high of $42.50. The firm has a fifty day simple moving average of $7.45 and a 200-day simple moving average of $7.65.
About DocMorris
DocMorris is a leading European online pharmacy brand and a subsidiary of the Swiss-based Zur Rose Group (OTCMKTS:ZRSEF). Through its digital platform, the company offers mail-order dispensing of prescription medications and over-the-counter health products directly to consumers’ homes.
The company’s core services include the online sale and delivery of prescription and non-prescription drugs, health supplements, personal care items and medical devices. Leveraging its e-commerce infrastructure and proprietary pharmacy management systems, DocMorris also provides digital health solutions such as telemedicine consultations, medication management tools and mobile app-based healthcare services.
Originally launched in the early 2000s in Germany, DocMorris has expanded its reach to serve customers in multiple European countries, including the Netherlands, Belgium, Luxembourg and Switzerland.
Recommended Stories
- Five stocks we like better than DocMorris
- AirJoule Unveils Prime System, Clearing Path to Commercialization
- Copper Stocks Are Getting a Bigger Spotlight as Gold’s Rally Cracks
- Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets
- Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case
Receive News & Ratings for DocMorris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocMorris and related companies with MarketBeat.com's FREE daily email newsletter.
